DCTH
DELCATH SYSTEMS, INC.
$11.72
-0.38%
$404.6M
No data for this timeframe.
Vol
Market Cap$404.6M
Cap SizeSmall Cap
Inst. Holders50 funds
Inst. Value$62.3M
Inst. Activity9 buys / 6 sells
Insider Activity2B / 0S
Insider Net $$150.3K
SEC Reports7
Exchange Nasdaq·Sector Surgical & Medical Instruments & Apparatus·Inc. DE·CIK 0000872912·Prev Close $11.77
Recent Activity
Jun 11, 2026
SEC
In Q3 2025, three institutional buyers (State Street, UBS, RenTech) added $1.0M in DCTH positions, while four sellers (F
INST-CLUSTER — Impact 4/10
Jun 9, 2026
Event
Hepzato Kit
WARNING: PERI-PROCEDURAL COMPLICATIONS, MYELOSUPPRESSION Severe peri-procedural complications includ
Jun 8, 2026
short_volume
Short Volume: DCTH — 66.8% short (0.4M / 0.7M)
Short: 441,075 | Exempt: 989 | TRF Vol: 660,212 | Short Ratio: 66.8% | Off-exchange volume (dark poo
May 14, 2026
SEC
Delcath Systems filed an 8-K reporting that stockholders approved an amendment to the 2020 Omnibus Equity Incentive Plan
8-K — Impact 3/10
May 13, 2026
Insider
CZEREPAK ELIZABETH was granted 22,500 shares
Director
May 13, 2026
Insider
SALAMON STEVEN A J was granted 22,500 shares
Director
May 13, 2026
Insider
Aharon Gil was granted 22,500 shares
Director
May 7, 2026
SEC
Delcath Systems reported Q1 2026 revenue of $25.0M (+26% YoY), beating the $23.4M consensus, but posted a GAAP net loss
8-K — Impact 5/10
Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$21.35 (Feb 2026)
Current $11.72
Low $16.00
Median $21.00
High $29.76
5 analysts
$16.00
$29.76
Analyst Ratings
4Strong Buy
8Buy
1Hold
0Sell
0Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Feb 26, 2026 | BTIG | MAINTAIN | Buy → Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.09 ▲ +6.9% | $-0.16 — $-0.05 | -225% YoY | 4 |
| Next Q | $-0.21 ▲ +3.9% | $-0.29 — $-0.13 | -1138% YoY | 4 |
| Current FY | $-0.60 ▲ +4.6% | $-0.91 — $-0.44 | -856% YoY | 4 |
| Next FY | $-0.51 ▼ -12.8% | $-1.23 — $-0.15 | 16% YoY | 4 |
Latest Reports
MIXED
INST-CLUSTER
4/10
In Q3 2025, three institutional buyers (State Street, UBS, RenTech) added $1.0M in DCTH positions, while four sellers (F
Jun 11, 2026
NEUTRAL
8-K
3/10
Delcath Systems filed an 8-K reporting that stockholders approved an amendment to the 2020 Omnibus Equity Incentive Plan
May 14, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $16.6M | ADD |
| VANGUARD CAPITAL MANAGEMENT LLC | $12.3M | — |
| STATE STREET CORP | $6.2M | ADD |
| MORGAN STANLEY | $3.6M | TRIM |
| GOLDMAN SACHS GROUP INC | $2.7M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| May 13, 2026 | CZEREPAK ELIZABETH | A | $0.00 |
| May 13, 2026 | SALAMON STEVEN | A | $0.00 |
| May 13, 2026 | Aharon Gil | A | $0.00 |
| May 13, 2026 | Martell Bridget | A | $0.00 |
| May 13, 2026 | Sylvester John | A | $0.00 |
50 institutional holders with $62.3M total value (6,708,898 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 9 institutions added/increased vs 6 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 1,784,466 | $16.6M | 26.6% | ADD +44.7% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1,329,288 | $12.3M | 19.8% | — |
| 3 | STATE STREET CORP | 664,428 | $6.2M | 9.9% | ADD +31.1% |
| 4 | MORGAN STANLEY | 385,524 | $3.6M | 5.7% | TRIM -44.7% |
| 5 | GOLDMAN SACHS GROUP INC | 289,131 | $2.7M | 4.3% | — |
| 6 | VANGUARD FIDUCIARY TRUST CO | 201,824 | $1.9M | 3.0% | — |
| 7 | ROYCE & ASSOCIATES LP | 195,000 | $1.8M | 2.9% | ADD +25.8% |
| 8 | MARSHALL WACE, LLP | 191,630 | $1.8M | 2.9% | DOUBLED +687.2% |
| 9 | CIBC WORLD MARKET INC. | 189,737 | $1.8M | 2.8% | — |
| 10 | VANGUARD PORTFOLIO MANAGEMENT LLC | 178,036 | $1.7M | 2.7% | — |
| 11 | RENAISSANCE TECHNOLOGIES LLC | 155,300 | $1.4M | 2.3% | TRIM -57.1% |
| 12 | Trexquant Investment LP | 104,150 | $966.5K | 1.6% | — |
| 13 | Nuveen, LLC | 103,774 | $963.0K | 1.5% | ADD +56.4% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 78,625 | $729.6K | 1.2% | DOUBLED +578.8% |
| 15 | CITADEL ADVISORS LLC | 77,264 | $717.0K | 1.2% | TRIM -44.1% |
| 16 | CITADEL ADVISORS LLC | 64,700 | $600.4K | 1.0% | TRIM -44.1% |
| 17 | BANK OF AMERICA CORP /DE/ | 57,729 | $535.7K | 0.9% | ADD +54.0% |
| 18 | SEI INVESTMENTS CO | 44,058 | $408.9K | 0.7% | DOUBLED +100.0% |
| 19 | Mariner, LLC | 39,531 | $366.9K | 0.6% | — |
| 20 | CITADEL ADVISORS LLC | 38,800 | $360.1K | 0.6% | TRIM -44.1% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| ROYCE & ASSOCIATES LP | ADD | 155,000 | 195,000 | +25.8% | $1.8M | 2026-Q1 |
| MARSHALL WACE, LLP | DOUBLED | 24,342 | 191,630 | +687.2% | $1.8M | 2026-Q1 |
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 361,599 | 155,300 | -57.1% | $1.4M | 2026-Q1 |
| Nuveen, LLC | ADD | 66,358 | 103,774 | +56.4% | $963.0K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | ADD | 37,480 | 57,729 | +54.0% | $535.7K | 2026-Q1 |
| SEI INVESTMENTS CO | DOUBLED | 22,029 | 44,058 | +100.0% | $408.9K | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | TRIM | 52,140 | 38,524 | -26.1% | $357.5K | 2026-Q1 |
| ExodusPoint Capital Management, LP | NEAR_EXIT | 496,705 | 35,968 | -92.8% | $333.8K | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | TRIM | 47,079 | 22,289 | -52.7% | $206.8K | 2026-Q1 |
| NOMURA HOLDINGS INC | NEAR_EXIT | 64,367 | 15,717 | -75.6% | $145.9K | 2026-Q1 |
| FMR LLC | TRIM | 7,482 | 4,820 | -35.6% | $44.7K | 2026-Q1 |
| CWM, LLC | DOUBLED | 117 | 3,162 | +2602.6% | $29.3K | 2026-Q1 |
| Rockefeller Capital Management L.P. | ADD | 305 | 555 | +82.0% | $5.2K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 16 | 151 | +843.8% | $1.4K | 2026-Q1 |
| PRICE T ROWE ASSOCIATES INC /MD/ | ADD | 16,076 | 21,479 | +33.6% | $200.00 | 2026-Q1 |
| ExodusPoint Capital Management, LP | ADD | 379,583 | 496,705 | +30.9% | $5.0M | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | ADD | 256,200 | 361,599 | +41.1% | $3.7M | 2025-Q4 |
| NOMURA HOLDINGS INC | DOUBLED | 20,617 | 64,367 | +212.2% | $650.1K | 2025-Q4 |
| BALYASNY ASSET MANAGEMENT L.P. | ADD | 30,756 | 52,140 | +69.5% | $526.6K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | TRIM | 110,641 | 37,480 | -66.1% | $378.5K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 18,541 | 32,820 | +77.0% | $331.5K | 2025-Q4 |
| ALPS ADVISORS INC | ADD | 16,874 | 28,999 | +71.9% | $292.9K | 2025-Q4 |
| MARSHALL WACE, LLP | NEAR_EXIT | 288,763 | 24,342 | -91.6% | $245.9K | 2025-Q4 |
| GROUP ONE TRADING LLC | DOUBLED | 1,886 | 16,318 | +765.2% | $164.8K | 2025-Q4 |
| FMR LLC | DOUBLED | 262 | 7,482 | +2755.7% | $75.6K | 2025-Q4 |
7 unique insiders with 7 transactions. Net insider value: $150.3K ($150.3K bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 13, 2026 | CZEREPAK ELIZABETH | Director | AWARD | 22,500 | — | — |
| May 13, 2026 | SALAMON STEVEN A J | Director | AWARD | 22,500 | — | — |
| May 13, 2026 | Aharon Gil | Director | AWARD | 22,500 | — | — |
| May 13, 2026 | Martell Bridget A | Director | AWARD | 22,500 | — | — |
| May 13, 2026 | Sylvester John Richard | Director | AWARD | 22,500 | — | — |
| Mar 6, 2026 | Pennell Sandra | Chief Financial Officer | BUY | 5,533 | $9.04 | $50.0K |
| Mar 2, 2026 | MICHEL GERARD J | CHIEF EXECUTIVE OFFICER | BUY | 11,200 | $8.96 | $100.3K |
7 SEC filing reports analyzed. Sentiment: 3 bullish, 0 bearish, 1 mixed, 3 neutral. Avg impact: 5.0/10.
MIXED
INST-CLUSTER
4/10
In Q3 2025, three institutional buyers (State Street, UBS, RenTech) added $1.0M in DCTH positions, w
Jun 11, 2026
NEUTRAL
8-K
3/10
Delcath Systems filed an 8-K reporting that stockholders approved an amendment to the 2020 Omnibus E
May 14, 2026
NEUTRAL
8-K
5/10
Delcath Systems reported Q1 2026 revenue of $25.0M (+26% YoY), beating the $23.4M consensus, but pos
May 7, 2026
NEUTRAL
DEFA14A
3/10
Delcath Systems, Inc. filed definitive additional proxy materials (DEFA14A) related to a shareholder
Apr 2, 2026
BULLISH
CLUSTER
6/10
Both the CEO and CFO of Delcath Systems purchased shares in the open market within the past week, co
Mar 6, 2026
BULLISH
INST-CLUSTER
6/10
Three major passive institutions — Morgan Stanley, Schwab, and UBS — significantly increased their p
Feb 28, 2026
BULLISH
8-K
8/10
Delcath Systems reported strong financial results for Q4 and full year 2025, with full-year revenue
Feb 26, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Feb 2026): 92% buy across 13 analysts — 4 strong buy, 8 buy, 1 hold, 0 sell, 0 strong sell. No current recommendation available.
Analyst Price Targets
Historical data — last covering-analyst action Feb 2026. No current recommendation available.
$21.35 mean target (Feb 2026)
$16.00 Low
$29.76 High
| Metric | Value |
|---|---|
| Current Price | $11.72 |
| Target Low | $16.00 |
| Target Mean | $21.35 |
| Target Median | $21.00 |
| Target High | $29.76 |
| # Analysts | 5 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.09 | $-0.16 | $-0.05 | -225.0% | +6.9% | 0↑ 3↓ | $0.0B | 8.7% | 4 |
| Next Q 2026-09-30 |
$-0.21 | $-0.29 | $-0.13 | -1137.5% | +3.9% | 0↑ 3↓ | $0.0B | — | 4 |
| Current FY 2026-12-31 |
$-0.60 | $-0.91 | $-0.44 | -856.3% | +4.6% | 0↑ 5↓ | $0.1B | 21.1% | 4 |
| Next FY 2027-12-31 |
$-0.51 | $-1.23 | $-0.15 | 15.7% | -12.8% | 0↑ 4↓ | $0.1B | 26.5% | 4 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.087 | |
| 7d ago | $-0.094 | +0.007 |
| 30d ago | $-0.094 | +0.007 |
| 60d ago | $-0.114 | +0.027 |
| 90d ago | $-0.128 | +0.041 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 0 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Feb 26, 2026 | BTIG | MAINTAIN | Buy | Buy |
| Jan 9, 2026 | HC Wainwright & Co. | REITERATE | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| May 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Apr 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Mar 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Feb 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% | |
| Jan 1, 2026 | 4 | 8 | 1 | 0 | 0 | 92% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
Jun 9, 2026
FDA
Hepzato Kit
WARNING: PERI-PROCEDURAL COMPLICATIONS, MYELOSUPPRESSION Severe peri-procedural complications including hemorrhage, hepatocellular injury, and thrombo
Jun 8, 2026
short_volume
Short Volume: DCTH — 66.8% short (0.4M / 0.7M)
Short: 441,075 | Exempt: 989 | TRF Vol: 660,212 | Short Ratio: 66.8% | Off-exchange volume (dark pool + OTC)
May 7, 2026
earnings_calendar
DCTH Q1 2026 Earnings Scheduled — 2026-05-07
Feb 26, 2026
earnings_calendar
DCTH Q4 2025 Earnings Before Market Open — 2026-02-26
Feb 23, 2026
short_interest
FTD: DCTH — 69,858 shares ($0.7M) failed to deliver
Settlement: 20260223, Price: $9.78, FTD Value: $683,211.24, DELCATH SYS INC